|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Treatment of older patients with mantle-cell lymphoma 显示文摘 | Kluin-Nelemans HC Hoster E Hermine O | 2012 | N Engl J Med2012，367，6： | 1 |
| 2 | The FLT3ITD mRNA level has a high prognostic impact in NPM1 mutated, but not in NPM1 unmutated AML with a normal karyotype显示文摘 | SCHNEIDER F HOSTER E UNTERHALT M | 2012 | Blood2012，119，： | 1 |
| 3 | Rituximab is the essential treatment modality that underlies the significant improvement in short and long term outcome of patients with advanced stage follicular lymphoma-a 10 year analysis of GLSG trials显示文摘 | Hiddemann W Hoster E Buske C | 2006 | Blood2006，108，： | 1 |
| 4 | Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma:results of a prospective randomized trial of the European MCL Network显示文摘 | Dreyling M Lenz G Hoster E | 2005 | Blood2005，105，： | 1 |
| 5 | Updateon the molecular pathogenesis and clinicaltreatment of Mantle Cell Lymphoma (MCL):minutes of the 9th European MCL Networkconference 显示文摘 | Dreyling M Hoster E Bea S | 2010 | Leukemia & Lymphoma2010，51，9： | 1 |
| 6 | A new prognostic index(MIPI) for patients with advanced- stage mantle cell lymphoma显示文摘 | Hoster E Dreyling M Klapper W | 2008 | Blood2008，111，： | 1 |
| 7 | Treatment of older patients with mantle-cell lymphoma显示文摘 | Kluin-Nelemans HC Hoster E Hermine O | 2012 | N Engl J Med2012，367，： | 1 |
| 8 | Anew prognostic index (MIPI) for patientswith advanced-stage mantle cell lymphoma显示文摘 | Hoster E Dreyling M Klapper W | 2008 | Blood2008，，2： | 1 |
| 9 | Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML)显示文摘 | Schneider F Hoster E Schneider S | 2012 | Ann Hematol2012，91，： | 1 |
| 10 | Treatment of older patients with mande--cell lymphoma显示文摘 | Kluin-Nelemans HC Hoster E Hermine O | 2012 | N Engl J Med2012，367，6： | 1 |
| 11 | NPM1 but not FL33 - ITD mutations predict early blast cell clearance and CR rate in patients with normal karyotype AML (NK - AML) or high - risk myelodysplastic syndrome (MDS) 显示文摘 | Schneider F Hoster E Unterhah M | 2009 | Blood2009，113，： | 1 |
| 12 | Immunochemotherapy with rituximab and cyclophosphamide,doxorubicin,vincristine,and prednisone significantly improves response and time to treatment failure,but not long-term outcome in patients with previously untreated mantle cell lymphoma:results of a prospective randomized trial of the German Low Grade Lymphoma Study Group(GLSG)显示文摘 | Lenz G Dreyling M Hoster E | 2005 | Clin Oncol2005，23，9： | 1 |
| 13 | Suppressing vertical displacement of lithiated silicon particles in high volumetric capacity battery electrodes显示文摘 | Yu D Y W Zhao M Hoster H E | 2015 | Chemelectrochem2015，2，8： | 1 |
| 14 | Treatment of older patients with mantle-cell lymphoma显示文摘 | Kluin-Nelemans HC Hoster E Hermine O | 2012 | N Engl J Med2012，367，6： | 1 |
| 15 | Early consolidation by mye- loablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progres- sion-free survival in mantle-cell lymphoma: results of a prospec- tive randomized trial of the European MCL Network显示文摘 | Dreyling M Lenz G Hoster E | 2005 | Blood2005，105，7： | 1 |
| 16 | Immunochemotherapy with rituximab and cyclophosphamide,doxorubicin,vincristine,and prednisone significantly improves response and time to treatment failure,but not long-term outcome in patients with previously untreated mantle cell lymphoma:results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG)显示文摘 | Lenz G Dreyling M Hoster E | 2005 | J Clin Oncol2005，23，9： | 1 |
| 17 | Age-dependent frequencies of NPMI mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML)显示文摘 | Schneider F Hoster E Schneider S | 2012 | Ann Hematol2012，91，1： | 1 |
| 18 | Immunochemotherapv with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG)显示文摘 | Denz G Dreyling M Hoster E | 2005 | J Clin Oncol2005，23，9： | 1 |
| 19 | Immunochemotherapy with rituximab and cyclophosphamide,doxorubicin,vincristine,and prednisone significantly improves response and time to treatment failure,but not long-term outcome in patients with previously untreated mantle cell lymphoma显示文摘 | Lenz G Dreyling M Hoster E | 2005 | J Clin Oncol2005，23，9： | 1 |
| 20 | The FLT31TD mRNA level has a high prognostic impact in NPM1 mutated,but not in NPM1unmutated,AML with a normal karyotype显示文摘 | Schneider F Hoster E Unterhalt M | 2012 | Blood2012，119，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员